SomnoMed Statistics

Total Valuation

SomnoMed has a market cap or net worth of AUD 95.09 million. The enterprise value is 82.50 million.

Market Cap	95.09M
Enterprise Value	82.50M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

SomnoMed has 216.11 million shares outstanding. The number of shares has increased by 108.63% in one year.

Current Share Class	n/a
Shares Outstanding	216.11M
Shares Change (YoY)	+108.63%
Shares Change (QoQ)	+42.66%
Owned by Insiders (%)	6.96%
Owned by Institutions (%)	28.57%
Float	103.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	152.25
PS Ratio	0.95
PB Ratio	2.00
P/TBV Ratio	2.42
P/FCF Ratio	117.49
P/OCF Ratio	41.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.35, with an EV/FCF ratio of 101.94.

EV / Earnings	-13.75
EV / Sales	0.82
EV / EBITDA	41.35
EV / EBIT	n/a
EV / FCF	101.94

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.12.

Current Ratio	1.81
Quick Ratio	1.52
Debt / Equity	0.12
Debt / EBITDA	2.96
Debt / FCF	7.30
Interest Coverage	-3.09

Financial Efficiency

Return on equity (ROE) is -15.51% and return on invested capital (ROIC) is -2.92%.

Return on Equity (ROE)	-15.51%
Return on Assets (ROA)	-2.14%
Return on Invested Capital (ROIC)	-2.92%
Return on Capital Employed (ROCE)	-4.58%
Revenue Per Employee	334,151
Profits Per Employee	-20,000
Employee Count	300
Asset Turnover	1.44
Inventory Turnover	6.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +109.52% in the last 52 weeks. The beta is 1.05, so SomnoMed's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+109.52%
50-Day Moving Average	0.53
200-Day Moving Average	0.44
Relative Strength Index (RSI)	35.95
Average Volume (20 Days)	68,814

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SomnoMed had revenue of AUD 100.25 million and -6.00 million in losses. Loss per share was -0.03.

Revenue	100.25M
Gross Profit	60.16M
Operating Income	-2.38M
Pretax Income	-4.22M
Net Income	-6.00M
EBITDA	-544,982
EBIT	-2.38M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 18.50 million in cash and 5.91 million in debt, giving a net cash position of 12.59 million or 0.06 per share.

Cash & Cash Equivalents	18.50M
Total Debt	5.91M
Net Cash	12.59M
Net Cash Per Share	0.06
Equity (Book Value)	47.46M
Book Value Per Share	0.22
Working Capital	18.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.32 million and capital expenditures -1.51 million, giving a free cash flow of 809,324.

Operating Cash Flow	2.32M
Capital Expenditures	-1.51M
Free Cash Flow	809,324
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 60.01%, with operating and profit margins of -2.38% and -5.99%.

Gross Margin	60.01%
Operating Margin	-2.38%
Pretax Margin	-4.21%
Profit Margin	-5.99%
EBITDA Margin	-0.54%
EBIT Margin	-2.38%
FCF Margin	0.81%

Dividends & Yields

SomnoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-108.63%
Shareholder Yield	-108.63%
Earnings Yield	-6.31%
FCF Yield	0.85%

Stock Splits

The last stock split was on November 27, 2009. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 27, 2009
Split Type	Reverse
Split Ratio	0.05

Scores

SomnoMed has an Altman Z-Score of 1.53. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.53
Piotroski F-Score	n/a